Clinical Trials

Friday, September 03, 2010

Home

Clinical Trials

Office Tools
Priority Diagrams
Ambulatory Care

Tissue Consent

You are here: Clinical Trials

Enter Search Terms

Save as PDF!

Studies

All Programs

(6 Records found)

CTO#: 101273
Kidney (101273)
Status: Active
Sponsor: MUSC & Novartis (CLBH589BUS16T)
A Phase I Safety and Tolerability Study of LBH589 in Combination with Sorafenib in Patients with Advanced Renal Cell Carcinoma and Non-small Cell Lung Carcinoma (NSCLC) of Non-squamous Histologies

HIPAA Authorization
Informed Consent
Protocol

...details...

CTO#: 101392
All Sites - Prevention & Control (101392)
Status: Active
Sponsor: Bayer (BAY 59-7939/12839)
MAGELLaN – Multicenter, rAndomized, parallel Group Efficacy and safety study for the prevention of venous thromboembolism in hospitalized medically iLL patients comparing rivaroxabaN with enoxaparin

No Documents currently available

...details...

CTO#: 101405
All Sites - Prevention & Control (101405)
Status: Active
Sponsor: MUSC (101405)
EX-VIVO Study of Serpin Biomarkers in Human Plasmas and RBCs

No Documents currently available

...details...

CTO#: 101427
All Sites - Prevention & Control (101427)
Status: Active
Sponsor: MUSC (101427)
Cancer Prevention & Wellness in the Low Country Faith-Based Community

No Documents currently available

...details...

CTO#: 101453
All Sites - Prevention & Control (101453)
Status: Active
Sponsor: SWOG (S0702)
A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment

HIPAA
Informed Consent
Protocol

...details...

CTO#: 101454
All Sites - Prevention & Control (101454)
Status: Active
Sponsor: SWOG (S0916)
A Phase II, Window Trial of the Anti-CCR2 Antibody MLN1202 (NSC-751448) in Patients with Bone Metastases

HIPAA
Informed Consent
Protocol

...details...